Search Results - Koen Vermeulen
- Showing 1 - 4 results of 4
-
1
-
2
Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma by Anthony Waked, Melissa Crabbé, Virginie Neirinckx, Sunay Rodriguez Pérez, Jasmien Wellens, Bernard Rogister, M. Abderrafi Benotmane, Koen Vermeulen
Published in EJNMMI Radiopharmacy and Chemistry (2024-07-01)Get full text
Article -
3
[11C]HSP990 PET as a translational tool to investigate the role of Hsp90 in tumours and support the development of Hsp90 therapeutics by Romy Cools, Valeria Narykina, Koen Vermeulen, Sanket J. Mishra, Brian S. J. Blagg, Marleen Derweduwe, Frederik De Smet, Aaron Ziani-Zeryouh, Matteo Riva, An Coosemans, Frederic Rousseau, Joost Schymkowitz, Guy Bormans
Published in EJNMMI Radiopharmacy and Chemistry (2025-09-01)Get full text
Article -
4
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [<sup>153</sup>Sm]Sm-DOTA-TATE by Koen Vermeulen, Michiel Van de Voorde, Charlotte Segers, Amelie Coolkens, Sunay Rodriguez Pérez, Noami Daems, Charlotte Duchemin, Melissa Crabbé, Tomas Opsomer, Clarita Saldarriaga Vargas, Reinhard Heinke, Laura Lambert, Cyril Bernerd, Andrew R. Burgoyne, Thomas Elias Cocolios, Thierry Stora, Maarten Ooms
Published in Pharmaceutics (2022-11-01)Get full text
Article
